Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

14.84
Delayed Data
As of 4:00pm ET
 -0.70 / -4.50%
Today’s Change
7.78
Today|||52-Week Range
20.25
+42.56%
Year-to-Date

Today’s Trading

Previous close15.54
Today’s open15.53
Day’s range14.78 - 15.68
Volume271,701
Average volume (3 months)392,404
Market cap$734.6M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-57.21%
Earnings growth (this year)+28.41%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales255.79
Price/Book8.81

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.09+0.29%
AKAOAchaogen Inc+0.19+1.74%
SPPISpectrum Pharmaceuti...-0.56-2.91%
FLXNFlexion Therapeutics...-1.21-4.72%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.7M
Net profit margin-8,843.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
John P. Butler
Vice President-
Operations
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts